Hualan Biological Engineering, Inc.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Joint Venture, Public
- Established
- 1992-03-30
- Employees
- 3.7K
- Market Cap
- $3.8B
- Website
- http://www.hualanbio.com
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002
Phase 2
Completed
- Conditions
- Meningitis
- Interventions
- Biological: Group ACYW135 Meningococcal Polysaccharide Vaccine
- First Posted Date
- 2012-08-09
- Last Posted Date
- 2012-08-09
- Lead Sponsor
- Hualan Biological Engineering, Inc.
- Target Recruit Count
- 360
- Registration Number
- NCT01661738
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001
Phase 1
Completed
- Conditions
- Meningitis
- Interventions
- Biological: Group ACYW135 Meningococcal Polysaccharide Vaccine
- First Posted Date
- 2012-08-09
- Last Posted Date
- 2012-08-09
- Lead Sponsor
- Hualan Biological Engineering, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01661725
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003
Phase 3
Completed
- Conditions
- Meningitis
- Interventions
- Biological: ACYW135 Meningococcal Polysaccharide VaccineBiological: A+C Meningococcal Polysaccharide Vaccine
- First Posted Date
- 2012-08-09
- Last Posted Date
- 2012-08-09
- Lead Sponsor
- Hualan Biological Engineering, Inc.
- Target Recruit Count
- 900
- Registration Number
- NCT01661751
Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine
Not Applicable
Completed
- Conditions
- Human Influenza
- Interventions
- Biological: Inactivated Influenza VaccineBiological: Inactivated Influenza Vaccine of PasteurBiological: Inactivated Influenza Vaccine of GSK
- First Posted Date
- 2012-04-02
- Last Posted Date
- 2012-06-20
- Lead Sponsor
- Hualan Biological Engineering, Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT01568788
- Locations
- 🇨🇳
Yanting County, Mianyang, Sichuan, China
Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation)
Phase 3
Completed
- Conditions
- Influenza
- Interventions
- Biological: Influenza split vaccineBiological: Influenza split vaccine of 15 μg HA
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2012-09-06
- Lead Sponsor
- Hualan Biological Engineering, Inc.
- Target Recruit Count
- 900
- Registration Number
- NCT01554813
- Locations
- 🇨🇳
Jiangsu Provincial Center for Disease Prevention and Control, Nanjing, Jiangsu, China
Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)
Phase 3
Completed
- Conditions
- Influenza
- Interventions
- Biological: Influenza Split VaccineBiological: Inactivated Influenza Vaccine
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2012-09-06
- Lead Sponsor
- Hualan Biological Engineering, Inc.
- Target Recruit Count
- 810
- Registration Number
- NCT01554826
- Locations
- 🇨🇳
Jiangsu Provincial Center for Disease Prevention and Control, Huaian, Jiangsu, China
Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine
Phase 4
Completed
- Conditions
- Human Influenza
- Interventions
- Biological: Inactivated influenza split vaccine
- First Posted Date
- 2012-01-19
- Last Posted Date
- 2012-08-14
- Lead Sponsor
- Hualan Biological Engineering, Inc.
- Target Recruit Count
- 6000
- Registration Number
- NCT01511744
- Locations
- 🇨🇳
Henan Province Center for Disease Preventionand Control, Zhengzhou, Henan, China
© Copyright 2025. All Rights Reserved by MedPath